<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03048370</url>
  </required_header>
  <id_info>
    <org_study_id>042-2016</org_study_id>
    <nct_id>NCT03048370</nct_id>
  </id_info>
  <brief_title>Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia</brief_title>
  <official_title>Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre for Addiction and Mental Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre for Addiction and Mental Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine if individuals with schizophrenia have greater reactivity to
      vestibular stimulation than healthy controls. The physiological response of vestibular
      stimulation will be assessed with electronystagmography, which provides a measure of the
      intensity of the nystagmus via PSPV. Positive results would suggest greater vestibular system
      reactivity to vestibular stimulation may be a biomarker of schizophrenia.
      Pathophysiologically, increased vestibular reactivity to vestibular stimulation may reflect
      abnormal vestibular function or impaired central suppression of the vestibular ocular reflex.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In schizophrenia, there is no conclusive link between psychopathology and vestibular
      dysfunction and we are not aware of any data that exists on the range of responses to caloric
      vestibular stimulation (CVS) in persons with schizophrenia. Initial data from another CVS
      study from our group suggests individuals with schizophrenia have greater reactivity to body
      temperature (37°C) CVS, as measured by the peak slow phase velocity of the resulting
      nystagmus (PSPV), than would be expected from individuals without schizophrenia versus
      healthy participants. Intriguingly, CVS at 37°C should not theoretically produce a
      significant vestibulocular reflex response due to the stimulus' approximation to body
      temperature. Hence, the primary aim of this study is to determine if individuals with
      schizophrenia will have greater vestibular reactivity, as measured by nystagmus PSPV, to CVS
      in comparison with healthy participants. The secondary aim is to assess illness awareness pre
      and post CVS administration in attempts to replicate our previous observation. A total of 20
      patients with schizophrenia and 20 healthy control participants will be recruited. All
      participants will receive three conditions bilaterally: (1) body temperature (37°C)
      vestibular stimulation; (2) warm CVS (44°C), and (3) ice-cold CVS (4°C).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Each participant will successively receive 8 vestibular stimulation conditions. Side of stimulation will be randomized.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The participant will be blinded to the order of experimental conditions, as well as the person conducting specific ratings assessments.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Nystagmus response (peak slow phase velocity)</measure>
    <time_frame>Between 30 and 60 sec after each CVS condition</time_frame>
    <description>Nystagmus response will be measured at between thirty and 60 seconds post irrigations, looking for the highest velocities.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Illness awareness</measure>
    <time_frame>Before CVS session, 5 min after CVS, and 20 min after CVS</time_frame>
    <description>Changes in illness awareness will be assessed using a questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Left body temperature VS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Left body temperature (37°C) vestibular stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right body temperature VS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Right body temperature (37°C) vestibular stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left warm CVS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Left warm (44°C) caloric vestibular stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left cold CVS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Left cold (30°C) caloric vestibular stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right cold CVS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Right cold (30°C) caloric vestibular stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right warm CVS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Right warm (44°C) caloric vestibular stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left ice cold CVS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Left ice cold (4°C) caloric vestibular stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right ice cold CVS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Right ice cold (4°C) caloric vestibular stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left body temperature VS</intervention_name>
    <description>Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function</description>
    <arm_group_label>Left body temperature VS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right body temperature VS</intervention_name>
    <description>Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function</description>
    <arm_group_label>Right body temperature VS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left warm CVS</intervention_name>
    <description>Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function</description>
    <arm_group_label>Left warm CVS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right warm CVS</intervention_name>
    <description>Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function</description>
    <arm_group_label>Right warm CVS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left cold CVS</intervention_name>
    <description>Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function</description>
    <arm_group_label>Left cold CVS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right cold CVS</intervention_name>
    <description>Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function</description>
    <arm_group_label>Right cold CVS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left ice cold CVS</intervention_name>
    <description>Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function</description>
    <arm_group_label>Left ice cold CVS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right ice cold CVS</intervention_name>
    <description>Caloric vestibular stimulation (CVS), which involves the irrigation of cold or warm water into the external ear canal, induces a temperature gradient across the semicircular canals of the vestibular apparatus stimulating the vestibular nerve. It is commonly used in both otolaryngology to assess vestibular function and neurology to test brain stem function</description>
    <arm_group_label>Right ice cold CVS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Schizophrenia group:

          1. Male or female inpatients or outpatients age ≥18

          2. Having a DSM-IV diagnosis of schizophrenia or schizoaffective disorder

          3. Voluntary and capable of consenting to participation in the research study

          4. Fluent in English

          5. Prescribed risperidone and no other antipsychotic drugs to standardize the effects of
             antipsychotics on vestibular reactivity to CVS

        Inclusion Criteria for Healthy Controls group:

          1. Male or female and age ≥18

          2. Voluntary and capable of consenting to participation in the research study

          3. Fluent in English

          4. Absence of history of psychiatric illness using the Mini-International
             Neuropsychiatric Interview (MINI)

        Exclusion Criteria for all participants:

          1. Serious unstable medical illness or any concomitant major medical or neurological
             illness

          2. Acute suicidal and/or homicidal ideation

          3. Formal thought disorder rating of over 2 on the Scale for Assessment of Positive
             Symptoms (SAPS) [patients only]

          4. DSM-IV substance dependence (except caffeine and nicotine) within one month prior to
             entering the study

          5. Pregnant women

          6. Positive urine drug screen

          7. History of external or middle ear pathology

          8. History or signs of middle ear surgery (e.g. Tympanoplasty, mastoidectomy)

          9. Signs of active ear disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Gerretsen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Addiction and Mental Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philip Gerretsen, MD, PhD</last_name>
    <phone>416-535-8501</phone>
    <phone_ext>39426</phone_ext>
    <email>philip.gerretsen@camh.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ariel Graff, MD, PhD</last_name>
    <phone>416-535-8501</phone>
    <phone_ext>34834</phone_ext>
    <email>ariel.graff@camh.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre for Addiction and Mental Health</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5S 2S1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philip Gerretsen, 416-535-8501</last_name>
      <phone>416-535-8501</phone>
      <phone_ext>39426</phone_ext>
      <email>philip.gerretsen@camh.ca</email>
    </contact>
    <contact_backup>
      <last_name>Ariel Graff, 416-535-8501</last_name>
      <phone>416-535-8501</phone>
      <phone_ext>34834</phone_ext>
      <email>ariel.graff@camh.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.camh.net/research</url>
    <description>Information about research at the Centre for Addiction and Mental Health, Canada's largest mental health and addiction teaching hospital, fully affiliated with the University of Toronto, and a PAHO/WHO Collaborating Centre</description>
  </link>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2016</study_first_submitted>
  <study_first_submitted_qc>February 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre for Addiction and Mental Health</investigator_affiliation>
    <investigator_full_name>Philip Gerretsen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

